Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Goodman

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
The American Journal of Psychiatry|September 1, 1997
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorderL C Barr, W K Goodman, A Anand, et al.
Brain Stimulation|February 7, 2012
Rebound symptoms following battery depletion in the NIH OCD DBS cohort: clinical and reimbursement issuesA K Vora, H Ward, K D Foote, et al.
Depression and Anxiety|January 1, 1996
Subclinical obsessive-compulsive disorder in college studentsM R Morris, R K Blashfield, B Rankupalli, et al.
The American Journal of Psychiatry|August 1, 1987
Treatment of severe obsessive-compulsive disorder with fluvoxamineL H Price, W K Goodman, D S Charney, et al.
The Journal of Clinical Psychiatry|June 1, 1993
Biological approaches to treatment-resistant obsessive compulsive disorderW K Goodman, C J McDougle, L C Barr, et al.
The American Journal of Psychiatry|July 1, 1986
Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three casesW K Goodman, D S Charney, L H Price, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1990
Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorderP L Delgado, W K Goodman, L H Price, et al.
The Journal of Clinical Psychiatry|April 1, 1992
The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studiesL C Barr, W K Goodman, L H Price, et al.
Psychopharmacology Bulletin|January 1, 1989
Fluvoxamine as an antiobsessional agentW K Goodman, L H Price, S A Rasmussen, et al.
Psychopharmacology|January 1, 1987
Effects of yohimbine in obsessive compulsive disorderS A Rasmussen, W K Goodman, S W Woods, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
The American Journal of Psychiatry|September 1, 1997
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorderL C Barr, W K Goodman, A Anand, et al.
Brain Stimulation|February 7, 2012
Rebound symptoms following battery depletion in the NIH OCD DBS cohort: clinical and reimbursement issuesA K Vora, H Ward, K D Foote, et al.
Depression and Anxiety|January 1, 1996
Subclinical obsessive-compulsive disorder in college studentsM R Morris, R K Blashfield, B Rankupalli, et al.
The American Journal of Psychiatry|August 1, 1987
Treatment of severe obsessive-compulsive disorder with fluvoxamineL H Price, W K Goodman, D S Charney, et al.
The Journal of Clinical Psychiatry|June 1, 1993
Biological approaches to treatment-resistant obsessive compulsive disorderW K Goodman, C J McDougle, L C Barr, et al.
The American Journal of Psychiatry|July 1, 1986
Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three casesW K Goodman, D S Charney, L H Price, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1990
Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorderP L Delgado, W K Goodman, L H Price, et al.
The Journal of Clinical Psychiatry|April 1, 1992
The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studiesL C Barr, W K Goodman, L H Price, et al.
Psychopharmacology Bulletin|January 1, 1989
Fluvoxamine as an antiobsessional agentW K Goodman, L H Price, S A Rasmussen, et al.
Psychopharmacology|January 1, 1987
Effects of yohimbine in obsessive compulsive disorderS A Rasmussen, W K Goodman, S W Woods, et al.
Pageof 10